R.N. Channick

Statistics

Publications

Citations

230

H-Index

Active since

2000

Affiliations

University of California San Diego(Current)

R.N. Channick is an author at University of California San Diego specializing in pulmonary hypertension, pulmonology, and endothelin receptor antagonists.

Publications per year

2000–2008

Publications

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study

R.N. Channick, G. Simonneau, Olivier Sitbon · ACC Current Journal Review · 2002 · 131 citations

Medicine, Pharmacology, Pharmacotherapy +14

Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report

Stephanie Hennigan, R.N. Channick, Silverman Gj · Lupus · 2008 · 60 citations

Life Sciences, Immunology, Internal Medicine +15

EFFECTS OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN IN PATIENTS WITH PULM HT: A RANDOMIZED PLACEBO CONTROLLED STUDY

R.N. Channick, G Simonneau, Olivier Sitbon · 2001 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +6

Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and hemodynamics in patients with pulmonary arterial hypertension Results of a double blind, randomized, placebo-controlled trial

R.N. Channick, Lewis J. Rubin, G. Simonneau et al. · 2000 · 10 citations

Medicine, Cardiology, Pharmacotherapy +17

1–4 of 4